| Dr Nadia Lee Norton Anspach, MD | |
|
200 W. Hospital Dr., Whiteriver, AZ 85941 | |
| (928) 338-4911 | |
| (928) 338-5508 |
| Full Name | Dr Nadia Lee Norton Anspach |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 200 W. Hospital Dr., Whiteriver, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699060889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ML60357383 (Washington) | Secondary |
| 207Q00000X | Family Medicine | MD2014-0774 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Whiteriver Phs Indian Hospital | Whiteriver, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dhhs Ihs Phoenix Area | 2668649567 | 63 |
News Archive
When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.
Politico: "Senate and House leaders are hoping to close up shop for the year by Dec. 18, even though neither chamber has figured out the end game for health care reform and must-pass appropriations bills." House Majority Leader Steny Hoyer, D-Md., said Tuesday that both he and Senate Majority Leader Harry Reid, D-Nev., are targeting that day 18 as "a last day for this session of Congress."
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.
Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 4 days ago
| Entity Name | Dhew Ind Hlth Sv Hlth Svs & Mntl Hlth Adm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083643738 PECOS PAC ID: 1759290901 Enrollment ID: O20031105000797 |
News Archive
When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.
Politico: "Senate and House leaders are hoping to close up shop for the year by Dec. 18, even though neither chamber has figured out the end game for health care reform and must-pass appropriations bills." House Majority Leader Steny Hoyer, D-Md., said Tuesday that both he and Senate Majority Leader Harry Reid, D-Nev., are targeting that day 18 as "a last day for this session of Congress."
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.
Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 4 days ago
| Entity Name | Dhhs Phs Naihs Crownpoint Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114960093 PECOS PAC ID: 0143128041 Enrollment ID: O20031230000393 |
News Archive
When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.
Politico: "Senate and House leaders are hoping to close up shop for the year by Dec. 18, even though neither chamber has figured out the end game for health care reform and must-pass appropriations bills." House Majority Leader Steny Hoyer, D-Md., said Tuesday that both he and Senate Majority Leader Harry Reid, D-Nev., are targeting that day 18 as "a last day for this session of Congress."
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.
Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 4 days ago
| Entity Name | Dhhs Ihs Phoenix Area |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427335140 PECOS PAC ID: 2668649567 Enrollment ID: O20120117000781 |
News Archive
When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.
Politico: "Senate and House leaders are hoping to close up shop for the year by Dec. 18, even though neither chamber has figured out the end game for health care reform and must-pass appropriations bills." House Majority Leader Steny Hoyer, D-Md., said Tuesday that both he and Senate Majority Leader Harry Reid, D-Nev., are targeting that day 18 as "a last day for this session of Congress."
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.
Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadia Lee Norton Anspach, MD P.o. Box 860, Whiteriver, AZ 85941 Ph: (928) 338-4911 | Dr Nadia Lee Norton Anspach, MD 200 W. Hospital Dr., Whiteriver, AZ 85941 Ph: (928) 338-4911 |
News Archive
When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.
Politico: "Senate and House leaders are hoping to close up shop for the year by Dec. 18, even though neither chamber has figured out the end game for health care reform and must-pass appropriations bills." House Majority Leader Steny Hoyer, D-Md., said Tuesday that both he and Senate Majority Leader Harry Reid, D-Nev., are targeting that day 18 as "a last day for this session of Congress."
Fujitsu Laboratories, Ltd. in collaboration with researchers at the University of Toronto (U of T) today announced the development of a technology for dramatically streamlining the creation of radiation treatment plans for Gamma Knife radiosurgery, leveraging Fujitsu's quantum-inspired computing technology, the Digital Annealer, which rapidly solves combinatorial optimization problems.
Athersys, Inc. announced today that MultiStem, Athersys' multipotent adult progenitor stem cell therapy, has been granted orphan drug designation by the U. S. Food and Drug Administration for the prevention of graft vs. host disease (GvHD).
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 4 days ago
Christopher K Jentoft, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 West Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-4911 Fax: 928-338-3520 | |
Dr. Pattie Jean Malone, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W. Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-4911 | |
Dr. James George Ard, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-4911 Fax: 928-338-5508 | |
Dr. David Alan Yost, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 West Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-4911 Fax: 928-338-3522 | |
Dr. John Christian Umhau, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 West Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-3555 Fax: 928-338-5508 | |
Dr. John S Condojani, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 W. Hospital Dr, Whiteriver, AZ 85941 Phone: 928-338-4911 | |
Edgar Alan Boone, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 West Hospital Drive, Whiteriver, AZ 85941 Phone: 928-338-4911 Fax: 928-338-5508 |